Bitte melden Sie sich an um selbst Rezensionen oder Kommentare zu erstellen.
Zitieren Sie diese Publikation
Mehr Zitationsstile
- bitte auswählen -
%0 Journal Article
%1 Osipenko2024
%A Osipenko, Leeza
%A Potey, Philippe
%A Perez, Bernardo
%A Kupryjanczuk, Alexandra
%A Angelov, Filip
%A Schuster, Alexandra
%A Mossialos, Elias
%D 2023
%I American Medical Association (AMA)
%K ClinicalBenefit DrugDevelopment marketing
%N 1
%P 46
%R 10.1001/jamainternmed.2023.6249
%T Provenance and Clinical Benefit of Medicines Introduced to the French Market, 2008 to 2018
%V 184
@article{Osipenko2024,
added-at = {2024-01-04T11:18:37.000+0100},
author = {Osipenko, Leeza and Potey, Philippe and Perez, Bernardo and Kupryjanczuk, Alexandra and Angelov, Filip and Schuster, Alexandra and Mossialos, Elias},
biburl = {https://www.bibsonomy.org/bibtex/2acdaef19ff54194d7243b7c618d41940/jepcastel},
doi = {10.1001/jamainternmed.2023.6249},
interhash = {d57453781943230d95641e515c7469f3},
intrahash = {acdaef19ff54194d7243b7c618d41940},
issn = {2168-6106},
journaltitle = {JAMA Internal Medicine},
keywords = {ClinicalBenefit DrugDevelopment marketing},
number = 1,
pages = 46,
publisher = {American Medical Association (AMA)},
timestamp = {2024-01-04T11:18:37.000+0100},
title = {Provenance and Clinical Benefit of Medicines Introduced to the French Market, 2008 to 2018},
volume = 184,
year = 2023
}